Mode of delivery and postpartum morbidity among HIV-infected women: The women and infants transmission study

Journal of Acquired Immune Deficiency Syndromes

Volumn 26, Issue 3, 2001, Pages 236-245

  Read, Jennifer S ^a   Tuomala, Ruth ^b   Kpamegan, Eloi ^c   Zorrilla, Carmen ^d   Landesman, Sheldon ^e   Brown, Gina ^f   Vajaranant, Mark ^g   Hammill, Hunter ^h   Thompson, Bruce ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c C TASC   (United States)

^d UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS; HIV infection; Mode of delivery; Postpartum morbidity

Indexed keywords

VIRUS RNA;

ANEMIA; ARTICLE; BLEEDING; CESAREAN SECTION; DELIVERY; DRUG USE; ENDOMETRITIS; FEMALE; FETUS MEMBRANE; FEVER; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; PREGNANCY; PRIORITY JOURNAL; URINARY TRACT INFECTION; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; WOUND INFECTION;

EID: 0035280934     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200103010-00005     Document Type: Article

References (33)

1. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective cohort studies
2. Elective caesarean section versus vaginal delivery in preventing vertical HIV-1 transmission: A randomised clinical trial
3. Maternal and neonatal morbidity and mortality in cesarean section
4. Maternal mortality and morbidity in cesarean section
5. Maternal consequences of caesarean section: A retrospective study of intra-operative and post-operative maternal complications of caesarean section during a 10-year period
6. The incidence of complications after caesarean section in 156 HIV-positive women
7. Post-cesarean section morbidity in HIV-positive women
8. Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment
9. Maternal complications after caesarean section in HIV infected women
10. Cesarean section and antiretroviral treatment
11. The Women and Infants Transmission Study (WITS) of maternal-infant HIV transmission: Study design, methods, and baseline data
12. Guideline for flow cytometric immunophenotyping: A report from the National Institute of Allergy and Infectious Diseases, Division of AIDS
13. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group
14. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
15. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes
16. Regression models for prognostic prediction: Advantages, problems, and suggested solutions
17. Clinical and microbiologic risk evaluation for post-cesarean section endometritis by multivariate discriminant analysis: Role of intraoperative mycoplasma, aerobes, and anaerobes
18. A clinical and microbiologic analysis of risk factors for puerperal endometritis
19. Asymptomatic parturient women with high-virulence bacteria in the amniotic fluid
20. Infectious morbidity, operative blood loss, and length of the operative procedure after cesarean delivery by method of placental removal and site of uterine repair
21. The effect of placental removal method on the incidence of postcesarean infections
22. Risk factors in the development of cesarean section infection
23. Infections complicating low-risk cesarean sections in community hospitals: Efficacy of antimicrobial prophylaxis
24. A double-blind randomized controlled trial on the use of prophylactic antibiotics in patients undergoing elective caesarean section
25. Antibiotic prophylaxis in low-risk cesarean section
26. Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects
27. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues